Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07208617

Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia

Efficacy Superiority Trial of Red Light Myopia Control Device Based on LED Light Source

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
206 (estimated)
Sponsor
Beijing Tongren Hospital · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Based on the Tongren Myopia and Amblyopia Therapeutic Apparatus (a 650nm low-level red-light device) developed by the research team in the previous phase, the device was modified by replacing the light source with LED light. Subsequently, a population study was conducted to evaluate its efficacy and safety in myopia prevention and control.

Conditions

Interventions

TypeNameDescription
DEVICERED-light device using LED light sourceThe light source type of red light is LED light source.
DEVICEControlFake light, with a light source power that is one-tenth of that of real LED light

Timeline

Start date
2026-02-12
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2025-10-06
Last updated
2026-02-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07208617. Inclusion in this directory is not an endorsement.

Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia (NCT07208617) · Clinical Trials Directory